share_log

T2 Biosystems | CORRESP: CORRESP

T2 Biosystems | CORRESP: CORRESP

T2 Biosystems | CORRESP:信函
美股SEC公告 ·  2024/07/27 01:36

Moomoo AI 已提取核心信息

T2 Biosystems, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 19, 2024. The company is seeking to have the registration statement become effective by 4:00 p.m. on July 29, 2024, or as soon as possible thereafter. This request was made under Rule 461(a) of the Securities Act of 1933, as amended. T2 Biosystems has asked to be notified of the registration statement's effectiveness via a phone call to their legal representative, N. Danny Shulman of Latham & Watkins LLP, and also to receive written confirmation.
T2 Biosystems, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 19, 2024. The company is seeking to have the registration statement become effective by 4:00 p.m. on July 29, 2024, or as soon as possible thereafter. This request was made under Rule 461(a) of the Securities Act of 1933, as amended. T2 Biosystems has asked to be notified of the registration statement's effectiveness via a phone call to their legal representative, N. Danny Shulman of Latham & Watkins LLP, and also to receive written confirmation.
t2 biosystems,inc.已正式向证券交易所(sec)提出请求,加速其在2024年7月19日首次提交的s-3表格的生效日期。该公司希望在2024年7月29日下午4:00之前或之后尽快生效。此请求是根据1933年修订后的证券法规则461(a)提出的。t2 biosystems要求通过电话通知其法律代表latham & watkins llp的n. danny shulman登记声明的生效,并收到书面确认。
t2 biosystems,inc.已正式向证券交易所(sec)提出请求,加速其在2024年7月19日首次提交的s-3表格的生效日期。该公司希望在2024年7月29日下午4:00之前或之后尽快生效。此请求是根据1933年修订后的证券法规则461(a)提出的。t2 biosystems要求通过电话通知其法律代表latham & watkins llp的n. danny shulman登记声明的生效,并收到书面确认。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息